Skip to main content

Peer Review reports

From: Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary

Original Submission
29 Dec 2011 Submitted Original manuscript
6 Feb 2012 Reviewed Reviewer Report - Gabriele Accetta
29 Mar 2012 Reviewed Reviewer Report - Francesco Chini
18 May 2012 Author responded Author comments - Zoltan Voko
Resubmission - Version 2
18 May 2012 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
11 Jun 2012 Reviewed Reviewer Report - Gabriele Accetta
15 Jun 2012 Reviewed Reviewer Report - Francesco Chini
14 Aug 2012 Author responded Author comments - Zoltan Voko
Resubmission - Version 5
14 Aug 2012 Submitted Manuscript version 5
29 Aug 2012 Reviewed Reviewer Report - Gabriele Accetta
17 Sep 2012 Author responded Author comments - Zoltan Voko
Resubmission - Version 6
17 Sep 2012 Submitted Manuscript version 6
14 Oct 2012 Reviewed Reviewer Report - Gabriele Accetta
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
18 Oct 2012 Editorially accepted
30 Oct 2012 Article published 10.1186/1471-2458-12-924

You can find further information about peer review here.

Back to article page